| Comprehensive molecular profiling of lung adenocarcinoma Cancer Genome Atlas Research Network Nature 511 (7511), 543, 2014 | 3423 | 2014 |
| Comprehensive genomic characterization of squamous cell lung cancers Cancer Genome Atlas Research Network Nature 489 (7417), 519, 2012 | 3399 | 2012 |
| Liver from bone marrow in humans ND Theise, M Nimmakayalu, R Gardner, PB Illei, G Morgan, L Teperman, ... Hepatology 32 (1), 11-16, 2000 | 1882 | 2000 |
| Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer CM Rudin, S Durinck, EW Stawiski, JT Poirier, Z Modrusan, DS Shames, ... Nature genetics 44 (10), 1111-1116, 2012 | 1006 | 2012 |
| Evolution of neoantigen landscape during immune checkpoint blockade in non–small cell lung cancerdynamics of neoantigen landscape during immunotherapy V Anagnostou, KN Smith, PM Forde, N Niknafs, R Bhattacharya, J White, ... Cancer discovery 7 (3), 264-276, 2017 | 708 | 2017 |
| Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and … P Argani, CR Antonescu, PB Illei, MY Lui, CF Timmons, R Newbury, ... The American journal of pathology 159 (1), 179-192, 2001 | 641 | 2001 |
| A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma: a phase II trial of safety, efficacy … E Lutz, CJ Yeo, KD Lillemoe, B Biedrzycki, B Kobrin, J Herman, E Sugar, ... Annals of surgery 253 (2), 328, 2011 | 416 | 2011 |
| A distinctive subset of PEComas harbors TFE3 gene fusions P Argani, S Aulmann, PB Illei, GJ Netto, J Ro, H Cho, S Dogan, M Ladanyi, ... The American journal of surgical pathology 34 (10), 1395-1406, 2010 | 366 | 2010 |
| A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune … DT Le, DG Brockstedt, R Nir-Paz, J Hampl, S Mathur, J Nemunaitis, ... Clinical cancer research 18 (3), 858-868, 2012 | 360 | 2012 |
| Detection of transcriptionally active high risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method JA Bishop, XJ Ma, H Wang, Y Luo, PB Illei, S Begum, JM Taube, ... The American journal of surgical pathology 36 (12), 1874, 2012 | 354 | 2012 |
| Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma JA Bishop, R Sharma, PB Illei Human pathology 41 (1), 20-25, 2010 | 354 | 2010 |
| Homozygous Deletion of CDKN2A and Codeletion of the Methylthioadenosine Phosphorylase Gene in the Majority of Pleural Mesotheliomas PB Illei, VW Rusch, MF Zakowski, M Ladanyi Clinical Cancer Research 9 (6), 2108-2113, 2003 | 330 | 2003 |
| Ewing Sarcomas With p53 Mutation or p16/p14ARF Homozygous Deletion: A Highly Lethal Subset Associated With Poor Chemoresponse HY Huang, PB Illei, Z Zhao, M Mazumdar, AG Huvos, JH Healey, ... Journal of clinical oncology 23 (3), 548-558, 2005 | 289 | 2005 |
| Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC) TR Cottrell, ED Thompson, PM Forde, JE Stein, AS Duffield, ... Annals of Oncology 29 (8), 1853-1860, 2018 | 279 | 2018 |
| Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical … F López-Ríos, S Chuai, R Flores, S Shimizu, T Ohno, K Wakahara, PB Illei, ... Cancer research 66 (6), 2970-2979, 2006 | 269 | 2006 |
| Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation SV Allander, PB Illei, Y Chen, CR Antonescu, M Bittner, M Ladanyi, ... The American journal of pathology 161 (5), 1587-1595, 2002 | 223 | 2002 |
| Herpes simplex virus hepatitis: case report and review B Kaufman, SA Gandhi, E Louie, R Rizzi, P Illei Clinical infectious diseases 24 (3), 334-338, 1997 | 221 | 1997 |
| Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids F López-Ríos, PB Illei, V Rusch, M Ladanyi The Lancet 364 (9440), 1157-1166, 2004 | 214 | 2004 |
| GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas A Cimino-Mathews, AP Subhawong, PB Illei, R Sharma, MK Halushka, ... Human pathology 44 (7), 1341-1349, 2013 | 210 | 2013 |
| Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers P Argani, J Hicks, AM De Marzo, R Albadine, PB Illei, M Ladanyi, ... The American journal of surgical pathology 34 (9), 1295, 2010 | 207 | 2010 |
